2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by HIRAYAMA, A. Articles by HOTHERSALL, J. S. Search for Related Content PubMed PubMed Citation Articles by HIRAYAMA, A. Articles by HOTHERSALL, J. S.

Inhibition of Neutrophil Superoxide Production by Uremic Concentrations of Guanidino Compounds

Free Radical Research Group, Division of Nephrology, Department of Medicine, University College London, London, United Kingdom.

Correspondence to Dr. John S. Hothersall, Institute of Urology and Nephrology, 67 Riding House Street, London W1P 7PN, United Kingdom. Phone: +44 171 380 9341; Fax: +44 171 637 7006; E-mail: j.hothersall{at}ucl.ac.uk

Abstract. In uremia, diminished reactive oxygen intermediate production is an important consequence of impaired neutrophil function. The effects of guanidino compounds, which are known uremic toxins, on neutrophil reactive oxygen intermediate production in vitro were studied. Neutrophils from healthy volunteers were exposed for 3 h to individual guanidino compounds or mixed guanidino compounds (GC_mix), at concentrations observed in uremic plasma. After removal of the guanidino compounds, the neutrophils were activated by adhesion, N-formylmethionylleucylphenylalanine, phorbol myristate acetate, or opsonized zymosan, and superoxide production was measured by monitoring lucigenin chemiluminescence. The direct effects of guanidino compounds on superoxide production in activated neutrophils were also measured. The energy status (ATP and creatine phosphate), antioxidant status (total glutathione), and glycolytic flux (lactate production) were measured. GC_mix pretreatment decreased superoxide production in activated neutrophils (activated by N-formylmethionylleucylphenylalanine or zymosan) by 50% (P < 0.01), decreased ATP concentrations by 60% (P < 0.05), and inhibited glycolytic flux (lactate production) by 45% (P < 0.01) but did not alter glutathione concentrations. Simultaneous GC_mix exposure and activation did not inhibit NADPH oxidase activity in cell lysates but inhibited superoxide formation in zymosan-activated intact neutrophils; this inhibition was reversed after removal of the guanidino compounds. Guanidinosuccinic acid, guanidinopropionic acid, and guanidinobutyric acid, when tested individually, were each as potent as GC_mix. The inhibition of neutrophil superoxide generation by guanidino compounds results from decreased energy status. Micromolar concentrations of guanidino compounds significantly inhibit neutrophil metabolism, with serious implications for the functions of neutrophils in host defenses.

This article has been cited by other articles:

				G. Cohen, J. Raupachova, T. Wimmer, R. Deicher, and W. H. Horl The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2512 - 2519. [Abstract] [Full Text] [PDF]

				Y. E. C. Taes, B. Marescau, A. De Vriese, P. P. De Deyn, E. Schepers, R. Vanholder, and J. R. Delanghe Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1330 - 1335. [Abstract] [Full Text] [PDF]

				F. Kawano, Y. Matsuoka, Y. Oke, Y. Higo, M. Terada, X. D. Wang, N. Nakai, H. Fukuda, S. Imajoh-Ohmi, and Y. Ohira Role(s) of nucleoli and phosphorylation of ribosomal protein S6 and/or HSP27 in the regulation of muscle mass Am J Physiol Cell Physiol, July 1, 2007; 293(1): C35 - C44. [Abstract] [Full Text] [PDF]

				A. F. Perna, D. Ingrosso, E. Satta, C. Lombardi, P. Galletti, A. D'Aniello, and N. G. De Santo Plasma Protein Aspartyl Damage Is Increased in Hemodialysis Patients: Studies on Causes and Consequences J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2747 - 2754. [Abstract] [Full Text] [PDF]

				W. H. Horl Hemodialysis Membranes: Interleukins, Biocompatibility, and Middle Molecules J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S62 - 71. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673